Ernexa Therapeutics Inc. — Investor Relations & Filings
Ernexa Therapeutics Inc. is a biopharmaceutical company developing cell therapies for advanced cancer and autoimmune diseases. The company's core technology platform engineers induced pluripotent stem cells (iPSCs) and differentiates them into induced mesenchymal stem cells (iMSCs). These engineered iMSCs are designed as scalable, off-the-shelf treatments that leverage the natural ability of MSCs to home to sites of tumors or inflammation. Once at the target site, the cells deliver therapeutic payloads, such as cytokines, to modulate the immune system. The company's lead candidate, ERNA-101, is being developed for the treatment of ovarian cancer. Its pipeline also includes ERNA-201, a cell therapy designed to target inflammation in autoimmune diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Major Shareholding Notification 2026 | 2026-05-14 | English | |
| ARS - Ernexa Therapeutics Inc. (0000748592) (Filer) | 2026-05-11 | English | |
| DEFA14A | 2026-05-11 | English | |
| DEF 14A | 2026-05-11 | English | |
| 10-Q - Ernexa Therapeutics Inc. (0000748592) (Filer) | 2026-05-11 | English | |
| 8-K | 2026-05-04 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46086876 | Major Shareholding Notification 2026 | 2026-05-14 | English | ||
| 45003027 | ARS - Ernexa Therapeutics Inc. (0000748592) (Filer) | 2026-05-11 | English | ||
| 46086834 | DEFA14A | 2026-05-11 | English | ||
| 46086868 | DEF 14A | 2026-05-11 | English | ||
| 45001283 | 10-Q - Ernexa Therapeutics Inc. (0000748592) (Filer) | 2026-05-11 | English | ||
| 46086896 | 8-K | 2026-05-04 | English | ||
| 46086900 | DEF 14C | 2026-04-13 | English | ||
| 46086907 | PRE 14C | 2026-04-01 | English | ||
| 46086912 | Regulatory Filings 2026 | 2026-03-31 | English | ||
| 33035304 | S-3/A - Ernexa Therapeutics Inc. (0000748592) (Filer) | 2026-03-24 | English | ||
| 33002553 | 8-K - Ernexa Therapeutics Inc. (0000748592) (Filer) | 2026-03-20 | English | ||
| 46086943 | S-3 | 2026-03-13 | English | ||
| 46087042 | 10-K | 2026-03-13 | English | ||
| 32880604 | 8-K - ERNEXA THERAPEUTICS INC. (0000748592) (Filer) | 2026-02-26 | English | ||
| 46087044 | Major Shareholding Notification 2026 | 2026-02-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Ernexa Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35259/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35259 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35259 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35259 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35259}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ernexa Therapeutics Inc. (id: 35259)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.